|
Xu, Huixin; Rajsombath, Molly M; Weikop, Pia et al. (2018) Enriched environment enhances ?-adrenergic signaling to prevent microglia inflammation by amyloid-?. EMBO Mol Med 10:
|
|
Li, Shaomin; Jin, Ming; Liu, Lei et al. (2018) Decoding the synaptic dysfunction of bioactive human AD brain soluble A? to inspire novel therapeutic avenues for Alzheimer's disease. Acta Neuropathol Commun 6:121
|
|
Yang, Ting; Li, Shaomin; Xu, Huixin et al. (2017) Large Soluble Oligomers of Amyloid ?-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate. J Neurosci 37:152-163
|
|
Walsh, Dominic M; Selkoe, Dennis J (2016) A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci 17:251-60
|
|
Selkoe, Dennis J; Hardy, John (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med 8:595-608
|
|
Jin, Ming; Selkoe, Dennis J (2015) Systematic analysis of time-dependent neural effects of soluble amyloid ? oligomers in culture and in vivo: Prevention by scyllo-inositol. Neurobiol Dis 82:152-163
|
|
Holmes, Oliver; Paturi, Swetha; Selkoe, Dennis J et al. (2014) Pen-2 is essential for ?-secretase complex stability and trafficking but partially dispensable for endoproteolysis. Biochemistry 53:4393-406
|
|
Muratore, Christina R; Rice, Heather C; Srikanth, Priya et al. (2014) The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. Hum Mol Genet 23:3523-36
|
|
Morris, John C; Selkoe, Dennis J (2011) Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview. Neurobiol Aging 32 Suppl 1:S1-3
|
|
Shepardson, Nina E; Shankar, Ganesh M; Selkoe, Dennis J (2011) Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 68:1239-44
|
Showing the most recent 10 out of 89 publications
